52 results on '"Adams, Kirkwood F."'
Search Results
2. Abstract 17332: A Multi-Marker Approach for Risk Stratification in Patients With Chronic Heart Failure: Insights From the HF-ACTION Trial
3. Blood pressure reactivity to psychological stress is associated with clinical outcomes in patients with heart failure
4. Effects of Coping Skills Training on Quality of Life, Disease Biomarkers, and Clinical Outcomes in Patients With Heart Failure: A Randomized Clinical Trial
5. A perspective on re-evaluating digoxinʼs role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile
6. Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties
7. Short-term effects and safety of an accelerated intravenous iron regimen in patients with heart failure and iron deficiency.: 276.
8. Relative bioavailability of tolvaptan administered via nasogastric tube and tolvaptan tablets swallowed intact
9. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial†
10. Case Studies in Hypervolemic Hyponatremia
11. Scientific Basis of Hyponatremia and Its Clinical Presentations
12. Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure
13. Acute Heart Failure Clinical Drug Development: From Planning to Proof of Activity to Phase III
14. Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure
15. Early worsening heart failure in patients admitted with acute heart failure - a new outcome measure associated with long-term prognosis?
16. Rapid Clinical Assessment of Patients with Acute Heart Failure: First Blood Pressure and Oxygen Saturation – Is That All We Need?
17. Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group
18. Prospective assessment of the occurrence of anemia in patients with heart failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry
19. Independent prognostic value of echocardiography and N-terminal pro-B-type natriuretic peptide in patients with heart failure
20. Clinical Predictors of In-Hospital Mortality in Acutely Decompensated Heart Failure—Piecing Together the Outcome Puzzle
21. Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition
22. The pathophysiology of acute heart failure—Is it all about fluid accumulation?
23. Acute heart failure syndromes: Clinical scenarios and pathophysiologic targets for therapy
24. Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction
25. Relationship of Depression to Death or Hospitalization in Patients With Heart Failure
26. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial
27. Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart Failure
28. β-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure
29. Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart Failure: Classification and Regression Tree Analysis
30. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
31. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure
32. Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure: A Randomized Controlled Trial
33. Survival rates are similar between African American and white patients with heart failure
34. Vasopressin: a new target for the treatment of heart failure
35. Tezosentan in patients with acute heart failure and acute coronary syndromes: Design of the Randomized Intravenous Tezosentan Study (RITZ-4)
36. Short-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart Failure : A Randomized Controlled Trial
37. Hemodynamics as surrogate end points for survival in advanced heart failure: An analysis from FIRST
38. Which β-blocker for heart failure?
39. Effect of Fluoxetine on Carvedilol Pharmacokinetics, CYP2D6 Activity, and Autonomic Balance in Heart Failure Patients
40. Rationale and design of the OPTIME CHF trial: Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure
41. Merck and Company Cardiovascular Fellowship: Effect of fluoxetine on carvedilol pharmacokinetics and autonomic balance in heart failure patients.: 229.
42. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)
43. Post hoc subgroup analysis and the truth of a clinical trial
44. Effect of fluoxetine on CYP2D6 expression in heart failure patients on carvedilol.: 8.
45. Clinical definition and epidemiology of advanced heart failure
46. Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers
47. Clinical predictors of worsening heart failure during withdrawal from digoxin therapy
48. 295. Merck and Company Cardiovascular Fellowship: Losartan metabolism in vivo: role of CYP3A4 and CYP2C9.
49. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
50. Withdrawal Of Digoxin From Patients With Chronic Heart Failure Treated With Angiotensin-Converting-Enzyme Inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.